.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Deloitte
Moodys
Johnson and Johnson
Colorcon
Medtronic
Daiichi Sankyo
UBS
Covington

Generated: December 18, 2017

DrugPatentWatch Database Preview

VALISONE Drug Profile

« Back to Dashboard

When do Valisone patents expire, and when can generic versions of Valisone launch?

Valisone is a drug marketed by Schering and is included in three NDAs.

The generic ingredient in VALISONE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Drug patent expirations by year for VALISONE

Medical Subject Heading (MeSH) Categories for VALISONE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
ScheringVALISONEbetamethasone valerateCREAM;TOPICAL016322-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ScheringVALISONEbetamethasone valerateOINTMENT;TOPICAL016740-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ScheringVALISONEbetamethasone valerateCREAM;TOPICAL016322-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
ScheringVALISONEbetamethasone valerateLOTION;TOPICAL016932-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Fish and Richardson
Argus Health
McKesson
Julphar
Citi
Johnson and Johnson
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot